FDA Panel Approves Pfizer's Covid Shot for Kids Age 5-11
The benefits of a Covid-19 vaccine for young children made by Pfizer Inc. and BioNTech SE exceed its risks, according to a panel of U.S. experts. Bloomberg's Drew Armstrong has more on "Bloomberg Markets: The Close."